Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer

Journal of Virology

Volumn 86, Issue 24, 2012, Pages 13689-13696

  Zhu, Jiangao ^a,b   Huang, Xiaopei ^b   Yang, Yiping ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ARGINASE 1; CATALASE; CD11B ANTIGEN; GAMMA INTERFERON; GRANZYME B; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; VIRUS VECTOR;

ADAPTIVE IMMUNITY; ADENOVIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL EXPANSION; CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GRANULOCYTE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE; SUPPRESSOR CELL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; BASE SEQUENCE; CELL PROLIFERATION; DNA PRIMERS; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MYELOID CELLS; REACTIVE OXYGEN SPECIES;

ADENOVIRIDAE;

EID: 84870674054     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01595-12     Document Type: Article

References (31)

1. Bowen JL, Olson JK. 2009. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease. J. Immunol. 183:6971-6980.
2. Condamine T, Gabrilovich DI. 2011. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 32:19-25.
3. Corzo CA, et al. 2010. HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207:2439-2453.
4. Dai Y, et al. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. U. S. A. 92:1401-1405.
5. Delano MJ, et al. 2007. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204:1463-1474.
6. De Santo C, et al. 2008. Invariant NKT cells reduce the immunosuppressive activity of influenzaAvirus-induced myeloid-derived suppressor cells in mice and humans. J. Clin. Invest. 118:4036-4048.
7. Dolcetti L, et al. 2008. Myeloid-derived suppressor cell role in tumorrelated inflammation. Cancer Lett. 267:216-225.
8. Gabrilovich DI, Nagaraj S. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9:162-174.
9. Goni O, Alcaide P, Fresno M. 2002. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+) immature myeloid suppressor cells. Int. Immunol. 14:1125-1134.
10. Hoechst B, et al. 2009. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 50:799-807.
11. Huang X, Yang Y. 2009. Innate immune recognition of viruses and viral vectors. Hum. Gene Ther. 20:293-301.
12. Ko HJ, et al. 2007. A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model. Cancer Res. 67:7477-7486.
13. Li H, Han Y, Guo Q, Zhang M, Cao X. 2009. Cancer-expanded myeloidderived suppressor cells induce anergy of NK cells through membranebound TGF-beta 1. J. Immunol. 182:240-249.
14. Liu C, et al. 2007. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 109:4336-4342.
15. Liu ZX, Govindarajan S, Okamoto S, Dennert G. 2000. NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J. Immunol. 164:6480-6486.
16. Martino A, et al. 2010. Mycobacterium bovis bacillus Calmette-Guerin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production. J. Immunol. 184:2038-2047.
17. Nagaraj S, et al. 2007. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat. Med. 13:828-835.
18. Ostrand-Rosenberg S, Sinha P. 2009. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182:4499-4506.
19. Peranzoni E, et al. 2010. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 22:238-244.
20. Ruzek MC, Kavanagh BF, Scaria A, Richards SM, Garman RD. 2002. Adenoviral vectors stimulate murine natural killer cell responses and demonstrate antitumor activities in the absence of transgene expression. Mol. Ther. 5:115-124.
21. Sander LE, et al. 2010. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207:1453-1464.
22. Suzuki E, Kapoor V, Jassar AS, Kaiser LR, Albelda SM. 2005. Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin. Cancer Res. 11:6713-6721.
23. Van Ginderachter JA, Beschin A, De Baetselier P, Raes G. 2010. Myeloid- derived suppressor cells in parasitic infections. Eur. J. Immunol. 40:2976-2985.
24. Voisin MB, Buzoni-Gatel D, Bout D, Velge-Roussel F. 2004. Both expansion of regulatory GR1+ CD11b+ myeloid cells and anergy of T lymphocytes participate in hyporesponsiveness of the lung-associated immune system during acute toxoplasmosis. Infect. Immun. 72:5487-5492.
25. Yang L, et al. 2008. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13:23-35.
26. Yang Y, Ertl HC, Wilson JM. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.
27. Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM. 1996. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3:137-144.
28. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. 2008. Subsets of myeloid- derived suppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
29. Zhu J, Huang X, Yang Y. 2008. A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo. Mol. Ther. 16:1300-1307.
30. Zhu J, Huang X, Yang Y. 2007. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J. Virol. 81:3170-3180.
31. Zhu J, Huang X, Yang Y. 2010. NKG2D is required for NK cell activation and function in response to E1-deleted adenovirus. J. Immunol. 185: 7480-7486.